167 related articles for article (PubMed ID: 6241257)
1. Immobilized IgG-aggregate-induced cytolytic activity of lymphocytes from patients with rheumatoid arthritis.
Fuson EW; Whittaker RL; Beard MR
J Clin Lab Immunol; 1984 Dec; 15(4):181-6. PubMed ID: 6241257
[TBL] [Abstract][Full Text] [Related]
2. Autocytotoxic cells in rheumatoid synovial fluids.
Sugiyama E; Suzuki H; Yano S
J Rheumatol; 1989 Mar; 16(3):276-9. PubMed ID: 2524590
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in rheumatoid arthritis by T-suppressor lymphocytes: experimental model in vitro.
Sultan AJ; Jawad AS; Berry H; Sharp J
Clin Rheumatol; 1986 Dec; 5(4):450-8. PubMed ID: 2949911
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of expontaneous cytotoxicity and antibody dependency by rheumatoid synovial fluid].
Noguera Hernando E; Kreisler M; Durantez A; Larrea Gayarre A; de Landazuri MO; Cruz MartÃnez J
Allergol Immunopathol (Madr); 1978; 6(3):253-62. PubMed ID: 717203
[TBL] [Abstract][Full Text] [Related]
5. Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis.
Fox RI; Fong S; Sabharwal N; Carstens SA; Kung PC; Vaughan JH
J Immunol; 1982 Jan; 128(1):351-4. PubMed ID: 6976376
[TBL] [Abstract][Full Text] [Related]
6. Nonspecific human lymphocyte-mediated cytotoxicity induced by immobilized IgG aggregate: regulation by suppressor cells.
Fuson EW; Sugantharaj DG; Hubbard RA
J Clin Lab Immunol; 1982 Jan; 7(1):55-60. PubMed ID: 6461768
[TBL] [Abstract][Full Text] [Related]
7. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid.
van Amelsfort JM; Jacobs KM; Bijlsma JW; Lafeber FP; Taams LS
Arthritis Rheum; 2004 Sep; 50(9):2775-85. PubMed ID: 15457445
[TBL] [Abstract][Full Text] [Related]
8. Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood.
Lawson CA; Brown AK; Bejarano V; Douglas SH; Burgoyne CH; Greenstein AS; Boylston AW; Emery P; Ponchel F; Isaacs JD
Rheumatology (Oxford); 2006 Oct; 45(10):1210-7. PubMed ID: 16571607
[TBL] [Abstract][Full Text] [Related]
9. Autologous and allogeneic MLC-reactivity in patients with rheumatoid arthritis.
Beck P; Burmester GR; Ledwoch A; Urban C; Kalden JR
J Clin Lab Immunol; 1981 Jul; 6(1):27-33. PubMed ID: 6455522
[TBL] [Abstract][Full Text] [Related]
10. In vitro studies on lymphocytotoxicity to synovial cells and Chang cells in rheumatoid arthritis patients and healthy controls.
Warnatz H; Thommes M
Z Rheumatol; 1979; 38(3-4):129-37. PubMed ID: 312567
[TBL] [Abstract][Full Text] [Related]
11. Study of the effects of antigammaglobulin factors on lymphocytes from patients with rheumatoid arthritis.
Astorga GP
Rheumatology; 1975; 6():80-6. PubMed ID: 1081732
[TBL] [Abstract][Full Text] [Related]
12. Evidence for activated peripheral blood T-cells in rheumatoid arthritis.
Keystone EC; Shore A; Miller RG; Tan P; Poplonski L; Leary P; Albert S
J Rheumatol Suppl; 1983 Dec; 11():85-92. PubMed ID: 6230449
[TBL] [Abstract][Full Text] [Related]
13. Enumeration of T cell subsets and functional suppressor cell assays in patients with rheumatoid arthritis and HLA-B27-associated arthritis.
Lemm G; Warnatz H
Z Rheumatol; 1984; 43(3):106-12. PubMed ID: 6236640
[TBL] [Abstract][Full Text] [Related]
14. Characterization of synovial T lymphocytes in rheumatoid arthritis. I. Production of IL-2 dependent T cell clones from synovial fluid and peripheral blood.
Ofosu-Appiah WA; McKenna RM; Warrington RJ; Wilkins JA
Clin Exp Immunol; 1986 Jun; 64(3):555-62. PubMed ID: 3491696
[TBL] [Abstract][Full Text] [Related]
15. Antibody-dependent direct cytotoxicity of human lymphocytes. II. Studies on peripheral blood lymphocytes, synovial fluid cells and sera from patients with rheumatoid arthritis.
Scheinberg MA; Cathcart ES
Clin Exp Immunol; 1976 May; 24(2):323-7. PubMed ID: 1084244
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.
Yudoh K; Matsuno H; Nakazawa F; Yonezawa T; Kimura T
Arthritis Rheum; 2000 Mar; 43(3):617-27. PubMed ID: 10728756
[TBL] [Abstract][Full Text] [Related]
17. Suppression of pokeweed mitogen-stimulated immunoglobulin production in patients with rheumatoid arthritis after treatment with total lymphoid irradiation.
Kotzin BL; Strober S; Kansas GS; Terrell CP; Engleman EG
J Immunol; 1984 Feb; 132(2):1049-55. PubMed ID: 6228589
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of the in vitro proliferative responses of blood and synovial fluid leukocytes of rheumatoid arthritis patients.
Reynolds MD; Abdou NI
J Clin Invest; 1973 Jul; 52(7):1627-31. PubMed ID: 4124157
[TBL] [Abstract][Full Text] [Related]
19. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
Mathsson L; Lampa J; Mullazehi M; Rönnelid J
Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
[TBL] [Abstract][Full Text] [Related]
20. Characterization of recirculating lymphocytes in rheumatoid arthritis patients: selective deficiency of natural killer cells in thoracic duct lymph.
Fox RI; Fong S; Tsoukas C; Vaughan JH
J Immunol; 1984 Jun; 132(6):2883-7. PubMed ID: 6609962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]